Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 4
1966 1
1968 3
1969 1
1970 1
1971 1
1972 1
1973 3
1974 4
1975 1
1976 3
1977 5
1978 3
1979 6
1980 2
1981 3
1982 4
1983 1
1984 1
1985 4
1986 1
1988 1
1989 2
1990 3
1991 3
1992 4
1993 5
1994 3
1995 7
1996 4
1997 6
1998 6
1999 6
2000 5
2001 3
2002 2
2003 3
2004 5
2005 5
2006 1
2007 4
2008 7
2009 5
2010 6
2011 6
2012 9
2013 6
2014 11
2015 17
2016 12
2017 14
2018 18
2019 19
2020 24
2021 23
2022 26
2023 19
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19.
Unoh Y, Uehara S, Nakahara K, Nobori H, Yamatsu Y, Yamamoto S, Maruyama Y, Taoda Y, Kasamatsu K, Suto T, Kouki K, Nakahashi A, Kawashima S, Sanaki T, Toba S, Uemura K, Mizutare T, Ando S, Sasaki M, Orba Y, Sawa H, Sato A, Sato T, Kato T, Tachibana Y. Unoh Y, et al. Among authors: suto t. J Med Chem. 2022 May 12;65(9):6499-6512. doi: 10.1021/acs.jmedchem.2c00117. Epub 2022 Mar 30. J Med Chem. 2022. PMID: 35352927 Free PMC article.
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Rüschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD; Herceptin Adjuvant (HERA) Trial Study Team. Piccart-Gebhart MJ, et al. Among authors: suto t. N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306. N Engl J Med. 2005. PMID: 16236737 Free article. Clinical Trial.
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.
Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D, Ohue M, Komori K, Shiomi A, Shiozawa M, Watanabe J, Suto T, Kinugasa Y, Takii Y, Bando H, Kobatake T, Inomata M, Shimada Y, Katayama H, Fukuda H; JCOG Colorectal Cancer Study Group. Kanemitsu Y, et al. Among authors: suto t. J Clin Oncol. 2021 Dec 1;39(34):3789-3799. doi: 10.1200/JCO.21.01032. Epub 2021 Sep 14. J Clin Oncol. 2021. PMID: 34520230 Clinical Trial.
The immunobiology of mTOR in autoimmunity.
Suto T, Karonitsch T. Suto T, et al. J Autoimmun. 2020 Jun;110:102373. doi: 10.1016/j.jaut.2019.102373. Epub 2019 Dec 9. J Autoimmun. 2020. PMID: 31831256 Review.
[Cytomegalovirus hepatitis].
Suto T, Sakamoto J. Suto T, et al. Ryoikibetsu Shokogun Shirizu. 1999;(24 Pt 2):123-5. Ryoikibetsu Shokogun Shirizu. 1999. PMID: 10201155 Review. Japanese. No abstract available.
Targeted therapies for non-small cell lung cancer.
Dempke WC, Suto T, Reck M. Dempke WC, et al. Among authors: suto t. Lung Cancer. 2010 Mar;67(3):257-74. doi: 10.1016/j.lungcan.2009.10.012. Epub 2009 Nov 14. Lung Cancer. 2010. PMID: 19914732 Review.
326 results